Step 7: preparation of intermediate 10-allyloxy-5-(3-(tert-butoxycarbonylamino)propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10g)
Using the procedure described in example 3 (step 13), 10-allyloxy-5-(3-methylsulfonyloxypropyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10f) (272 mg, 0.70 mmol) was converted to 10-allyloxy-5-(3-(tert-butoxycarbonylamino)propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10g) (189 mg, 0.46 mmol, 66%) after a purification on silica gel (DCM/Acetone 100/0 to 90/10).